Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [HEALTH]
2 clusters · 9 sources · 7 days · First seen · Last updated
European cancer research and precision oncology initiatives
Overview
The PRECISE (Predictive Relationships Explaining Cancer Genetic Interactions and Synthetic Essentiality) consortium has been launched to advance precision oncology across Europe. Co-founded by Human Technopole, the initiative involves over 30 research groups from more than 20 institutions across nine countries.
The consortium aims to move beyond descriptive cancer mapping to create predictive models that identify genetic vulnerabilities and therapeutic targets. By integrating functional genomics, experimental biology, and artificial intelligence, PRECISE seeks to explain the biological mechanisms driving tumor dependencies and forecast them in unexplored tumor contexts.
In a complementary development, the Arc-net Centre at the University of Verona has contributed over 70 patient-derived tumor models, including pancreatic and colorectal organoids, to the Human Cancer Models Initiative (HCMI) to support global oncological studies.
Entities
Nature Genetics · PRECISE · Human Technopole · Human Cancer Models Initiative · University of Verona
Timeline
-
22 days ago
[HEALTH] 3 sourcesPRECISE consortium launched to predict cancer vulnerabilitiesThe PRECISE European consortium, co-founded by Human Technopole, aims to use AI and functional genomics to predict cancer vulnerabilities and improve precision medicine.
-
28 days ago
[HEALTH] 6 sourcesEuropean research initiatives advance cancer prediction and modelingThe PRECISE European consortium is using AI and genomics to predict cancer vulnerabilities, while the University of Verona contributes over 70 tumor organoid models to the international HCMI project.
Sources
controcampus.it · dazebaonews.it · dirittoallasalute.net · insalutenews.it · italpress.com · panoramasanita.it · quotidianodelsud.it · salutedomani.com · we-news.com